Suppr超能文献

自互补 AAV 介导基因靶向并增强内切酶传递用于双链断裂修复。

Self-complementary AAV mediates gene targeting and enhances endonuclease delivery for double-strand break repair.

机构信息

UNC Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7352, USA.

出版信息

Gene Ther. 2010 Sep;17(9):1175-80. doi: 10.1038/gt.2010.65. Epub 2010 May 13.

Abstract

Adeno-associated virus (AAV) mediates gene targeting in humans by providing exogenous DNA for allelic replacement through homologous recombination. In comparison to other methods of DNA delivery or alternative DNA substrates, AAV gene targeting is reported to be very efficient, perhaps due to its single-stranded DNA genome, the inverted terminal repeats (ITRs), and/or the consequence of induced cellular signals on infection or uncoating. These viral attributes were investigated in the presence and absence of an I-Sce endonuclease-induced double-strand break (DSB) within a chromosomal defective reporter in human embryonic kidney cells. Gene correction was evaluated using self-complementary (sc) AAV, which forms a duplexed DNA molecule and results in earlier and robust transgene expression compared with conventional single-strand (ss) AAV genomes. An scAAV repair substrate was modestly enhanced for reporter correction showing no dependency on ssAAV genomes for this process. The AAV ITR sequences were also investigated in a plasmid repair context. No correction was noted in the absence of a DSB, however, a modest inhibitory effect correlated with the increasing presence of ITR sequences. Similarly, signaling cascades stimulated upon recombinant AAV transduction had no effect on plasmid-mediated DSB repair. Noteworthy, was the 20-fold additional enhancement in reporter correction using scAAV vectors, over ss versions, to deliver both the repair substrate and the endonuclease. In this case, homologous recombination repaired the defective reporter in 4% of cells without any selection. This report provides novel insights regarding the recombination substrates used by AAV vectors in promoting homologous recombination and points to the initial steps in vector optimization that could facilitate their use in gene correction of genetic disorders.

摘要

腺相关病毒 (AAV) 通过同源重组为等位基因替换提供外源 DNA,从而介导人类基因靶向。与其他 DNA 递送方法或替代 DNA 底物相比,AAV 基因靶向被报道非常有效,这可能是由于其单链 DNA 基因组、反向末端重复序列 (ITR) 以及/或感染或脱壳过程中诱导的细胞信号的结果。在人胚肾细胞中,在存在和不存在染色体缺陷报告基因内的 I-Sce 内切酶诱导的双链断裂 (DSB) 的情况下,研究了这些病毒属性。使用自我互补 (sc) AAV 评估基因校正,scAAV 形成双链 DNA 分子,与传统的单链 (ss) AAV 基因组相比,更早且更强有力地表达转基因。scAAV 修复底物对报告基因校正略有增强,表明该过程不依赖于 ssAAV 基因组。还在质粒修复背景下研究了 AAV ITR 序列。在不存在 DSB 的情况下没有观察到校正,但是随着 ITR 序列的增加,观察到适度的抑制作用。类似地,重组 AAV 转导后刺激的信号级联对质粒介导的 DSB 修复没有影响。值得注意的是,使用 scAAV 载体(而非 ss 版本)来递送修复底物和内切酶,可使报告基因校正增加 20 倍。在这种情况下,同源重组在没有任何选择的情况下修复了 4%的细胞中的缺陷报告基因。该报告提供了关于 AAV 载体在促进同源重组中使用的重组底物的新见解,并指出了在载体优化中可以促进其在遗传疾病基因矫正中的使用的初始步骤。

相似文献

引用本文的文献

1
Just a SNP away: The future of massively parallel reporter assay.仅一步之遥:大规模平行报告基因检测的未来。
Cell Insight. 2024 Oct 10;4(1):100214. doi: 10.1016/j.cellin.2024.100214. eCollection 2025 Feb.
2
CRISPR-Cas9-mediated homology-directed repair for precise gene editing.用于精确基因编辑的CRISPR-Cas9介导的同源定向修复
Mol Ther Nucleic Acids. 2024 Sep 26;35(4):102344. doi: 10.1016/j.omtn.2024.102344. eCollection 2024 Dec 10.
3
Advancements in Viral Gene Therapy for Gaucher Disease.戈谢氏病病毒基因治疗的进展。
Genes (Basel). 2024 Mar 15;15(3):364. doi: 10.3390/genes15030364.
5
Cell and gene therapy for kidney disease.肾脏疾病的细胞和基因治疗。
Nat Rev Nephrol. 2023 Jul;19(7):451-462. doi: 10.1038/s41581-023-00702-3. Epub 2023 Mar 27.
7
Molecular therapy of primary hyperoxaluria.原发性高草酸尿症的分子治疗。
J Inherit Metab Dis. 2017 Jul;40(4):481-489. doi: 10.1007/s10545-017-0045-3. Epub 2017 Apr 19.
10
Genome-editing Technologies for Gene and Cell Therapy.用于基因和细胞治疗的基因组编辑技术
Mol Ther. 2016 Mar;24(3):430-46. doi: 10.1038/mt.2016.10. Epub 2016 Jan 12.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验